meta|evidence COVID-19
  • Living systematic review and meta-analysis
  • All
  •   potential COVID-19 treatments
  • adjuvant therapies
  • anticoagulant
  • anticoagulant, curative dose
  • anticoagulant, pre-admission
  • anticoagulant, prophylactic dose
  • anticoagulation, intermediate prophylactic dose
  • Bivalirudin
  • enoxaparin
  • heparin at therapeutic dose
  • P2Y12 inhibitors
  • rivaroxaban
  • sulodexide
  • face mask
  • febuxostat
  • hydrogen-oxygen nebulizer
  • hyperbaric oxygen
  • nintedanib
  • paracetamol
  • pulmonary rehabilitation
  • anti-inflammatoty and immuno-therapy
  • anti-inflammatory therapies
  • anti GM-CSF
  • mavrilimumab
  • otilimab
  • clarithromycine
  • colchicine
  • Colchicine plus rosuvastatin
  • mepolizumab
  • naproxen, ibuprofen
  • non-steroidal anti-inflammatory drugs
  • Celecoxib
  • Ibuprofen
  • Indomethacin
  • selinexor
  • sodium aescinate
  • stem cells
  • tradipitant
  • vilobelimab (IFX-1)
  • Apilimod
  • corticosteroids
  • ciclesonide
  • dexamethasone
  • Dexamethasone 12mg
  • dexamethasone 6mg
  • Hydrocortisone
  • low-dose corticosteroids
  • methylprednisolone
  • Immunostimulants drugs
  • anti-PD-1 antibody
  • CD24Fc
  • convalescent plasma treatment
  • Deferred Convalescent plasma
  • Early convalescent plasma.
  • immunoglobulin therapy
  • inactivated mycobacterium vaccine
  • interferon
  • IFN beta-1a
  • high-dose IFN beta-1a
  • IFN beta-1b
  • IFN gamma
  • inhaled interferon
  • IFN alpha
  • pegylated interferon-α2b
  • recombinant super-compound interferon rSIFN-co
  • SNG001 inhaled interferon beta
  • interferon / TFF2
  • peginterferon
  • PNB001
  • Interleukin-2
  • levamisole
  • neutralizing antibody
  • amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences)
  • bamlanivimab monotherapy
  • bamlanivimab/etesevimab
  • Bebtelovimab (LY-CoV1404)
  • bevacizumab
  • cilgavimab and tixagevimab (Evusheld)
  • equine polyclonal antibodies INM005
  • regdanvimab (Regkirona- CT-P59-Celltrion)
  • sotrovimab (Xevudy; VIR-7831)
  • XAV-19
  • rhG-CSF
  • Immunosuppressants drugs
  • adalimumab
  • anakinra
  • anti-interleukin-6
  • clazakizumab
  • Levilimab
  • sarilumab
  • sarilumab azithromycin hydroxychloroquine
  • sarilumab high dose (400mg)
  • sarilumab low dose (200mg)
  • siltuximab
  • tocilizumab
  • canakinumab
  • complement inhibitors
  • conestat alfa
  • ravulizumab
  • CRAC-channel inhibitors (auxora)
  • eculizumab
  • emapalumab
  • fostamatinib
  • itolizumab
  • ixekizumab
  • jakotinib
  • janus kinase (JAK) inhibitor
  • baricitinib
  • baricitinib plus remdesivir
  • ruxolitinib
  • TD-0903
  • TD-0903 10mg
  • TD-0903 1mg
  • TD-0903 3mg
  • tofacitinib
  • lenzilumab
  • pamrevlumab
  • tacrolimus
  • tetrandrine
  • thalidomide
  • inhaled corticosteroids
  • budesonide
  • Kinase inhibitors
  • acalabrutinib
  • imatinib
  • leflunomide
  • meplazumab
  • pirfenidone
  • Polyinosinic-Polycytidylic Acid
  • sargramostim
  • statins
  • Atorvastatin
  • thymosin
  • antiandrogenic
  • 5-alpha-reductase inhibitors
  • dutasteride
  • progesterone
  • proxalutamide
  • antiviral and associated therapy
  • ASC09/ritonavir
  • azithromycin
  • azvudine
  • baloxavir marboxil
  • bromhexine
  • carrimycin
  • chloroquine and derivatives
  • chloroquine
  • hydroxychloroquine
  • zinc plus hydroxychloroquine
  • danoprevir / ritonavir
  • darunavir cobicistat
  • darunavir/cobicistat plus chloroquine
  • doxycycline
  • Emtricitabine/tenofovir plus colchicine plus rosuvastatin
  • favipiravir
  • favipiravir plus interferon
  • fluvoxamine
  • hydroxychloroquine plus macrolides
  • azithromycin plus hydroxychloroquine
  • Interferon plus lopinavir/ritonavir
  • ivermectin
  • ivermectin plus doxycycline
  • leronlimab
  • lopinavir / ritonavir plus ribavirin
  • lopinavir/ritonavir
  • lopinavir/ritonavir plus chloroquine
  • Lopinavir/ritonavir plus hydroxychloroquine
  • lopinavir/ritonavir plus interferon ß-1a
  • lopinavir/ritonavir, ribavirin and interferon beta-1b
  • molnupiravir
  • niclosamide
  • nirmatrelvir / ritonavir (Paxlovid)
  • nitazoxanide
  • opaganib
  • oseltamivir
  • oseltamivir plus chloroquin
  • remdesivir
  • ribavirin
  • ritonavir
  • sofosbuvir
  • sofosbuvir and daclatasvir
  • sofosbuvir and ledipasvir
  • tenofovir/emtricitabine
  • tenofovir/emtricitabine plus hydroxychloroquine
  • tranexamic acid
  • tranilast
  • triazavirin
  • umifenovir (arbidol)
  • zinc
  • control
  • placebo
  • prone positioning
  • standard of care
  • miscellaneous
  • acetylcysteine
  • alpha lipoic acid
  • anti-CK2
  • Aspirin
  • aviptadil
  • calcium channel blocker
  • camostat mesilate
  • Cannabidiol
  • continuous positive airway pressure (CPAP)
  • cytokine adsorption
  • diammonium glycyrrhizinate
  • dipyridamol
  • dornase alfa
  • expectorants and mucolytics
  • kinin-kallikrein inhibitors
  • melatonin
  • mouthrise and gargling agents
  • mouthrinses
  • N-Acetylcysteine
  • nasal spray
  • nasal spray containing Iota-Carrageenan
  • natural killer (NK) cells
  • nicotin
  • nigella sativa oil
  • nitric oxide (gas Inhalation or releasing solution)
  • omega-3 Polyunsaturated Fatty Acids
  • ozonated autohemotherapy
  • plasma exchange
  • povidone-iodine
  • previfenon (EGCG)
  • prostacyclin
  • PUL-042 inhalation solution
  • pyridostigmine
  • radiotherapy
  • sabizabulin
  • sildenafil
  • triiodothyronine (T3)
  • Oral antidiabetic drugs
  • dapagliflozin
  • DPP-4 inhibitor
  • metformin
  • Renin-angiotensin-system-acting agents
  • angiotensin converting enzyme inhibitors (ACEIs)
  • angiotensin receptor blockers (ARBs)
  • losartan
  • angiotensin-(1-7)
  • continuation of ACEI/ARB
  • discontinuation of ACEI/ARB
  • RAS blocker withdrawal
  • rhACE2
  • vaccines
  • BCG vaccination
  • CoVLP (MT-2766, Medicago)
  • DNA vaccine
  • Zy-Cov-D (Zydus Cadila)
  • ebola vaccine
  • first booster dose
  • heterologous prime-boost
  • Inactivated virus vaccine
  • CoronaVac (SinoVac)
  • Covaxin, Bharat Biotech (BBV152)
  • Shifa-Pharmed inactivated vaccine
  • Sinopharm Beijing (BBIBP-CorV)
  • Sinopharm Wuhan
  • mRNA vaccine
  • Comirnaty (tozinameran - Pfizer/BIONTECH)
  • CureVac
  • Spikevax (Moderna mRNA-1273 COVID-19 vaccine)
  • Non replicating viral vector
  • Ad26.RSV.preF (respiratory syncytial virus)
  • Ad26.ZEBOV ()
  • Ad26.ZIKV.001 (Ad26-Vectored Anti-Zika Virus Vaccine)
  • CanSino (Convidecia)
  • Covishield (Oxford/AZ formulation)
  • Janssen AD26 vaccine (JNJ-78436735)
  • Sputnik V (Gam-COVID-Vac)
  • Vaxzevria (AstraZeneca Oxford - ChAdOx1 nCoV-19)
  • protein subunit vaccine
  • Anhui Zhifei Longcom
  • CoVax-19 SpikoGen
  • Nuvaxovid (NVX-CoV2373) Novavax
  • Sanofi/GSK recombinant protein vaccine
  • SCB-2019
  • Replicating Viral Vector
  • seasonal influenza vaccines
  • virus-like particles vaccine
  • Medicago
  • Vitamins
  • vitamin C
  • zinc plus vitamin c
  • Vitamin D
 
  • All
  •   COVID 19 hospitalized
  • COVID 19 all comers
  • COVID-19 mild to moderate
  • COVID-19 severe or critically
  •   COVID 19 outpatients
  •   COVID-19 (hospitalized or not)
  •   COVID-19 prophylaxis (children)
  •   COVID-19 prophylaxis (excluding children)
  •   infections other than COVID-19
  •   Long COVID-19
  •   preventing respiratory virus transmission
  •   root
  •   secondary prevention